Dr. Hossein Ansari, MD

Dr. Ansari practices at Kaizen Brain Center in La Jolla, California.

Dr. Ansari's NPI, 1578774949, was assigned on May 25, 2007. Dr. Ansari holds California license A121526.

Dr. Ansari's primary practice is Kaizen Brain Center, at 4180 La Jolla Village Dr, La Jolla, CA 92037 in San Diego County. The practice phone is (866) 277-2659.

Dr. Ansari's primary practice is Kaizen Brain Center in La Jolla, California. Dr. Ansari is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Ansari to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ansari practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ansari's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ansari is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Ansari's licenses on file in 4 states: California, Ohio, West Virginia and Minnesota.

Dmand AI lists head injury, migraine and chronic headache and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Ansari treats.

CMS data shows 20,405 Medicare services from Dr. Ansari across 7 procedure codes in 2024, for 109 Medicare patients. Medicare paid $141,293 for them. Every service was in an office.

CMS counts 109 Medicare patients who saw Dr. Ansari in 2024. The largest group is 65 to 74, with 52 patients. 72% of them have high cholesterol, and 60% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ansari's median patient age at 48, with 82% women.

In 2024, Dr. Ansari wrote 913 Medicare Part D claims for 102 patients. 68% of them were for generic drugs. CMS names the drug for 687 of them, across 24 drugs with 11 or more claims each, at $317,295 in total drug cost. In 2023, CMS named 630 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ansari for performance year 2024, reported as part of a group. Dr. Ansari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ansari as offering telehealth.

Dmand AI links 18 papers to Dr. Ansari, published from 2013 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Migraine Disorders, Headache and Drug Interactions. Dr. Ansari has published most often in Headache. Dr. Ansari's most frequent co-authors are Bahman Guyuron, MD, Mohammed Muzammil Ahmed, MD and Sharona Ben-Haim, MD.

Dmand AI links Dr. Ansari to 1 clinical trial. Conditions studied include Headache and Migraine Disorders. Open Payments lists research payments to Dr. Ansari that name 1 trial.

CMS Open Payments shows 1,181 general payments to Dr. Ansari from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Amgen Inc. paid the most, $133,073. It also lists 2 research payments totaling $2,908 from 2020 to 2021, naming 1 clinical trial.

Dr. Ansari is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.